The Oncology Institute, Inc. TOI Interest coverage
Interest coverage at other companies
Other financials
Where this comes from
Calculated from The Oncology Institute, Inc.’s reported figures.
Based on trailing twelve months.
The official record: The Oncology Institute, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about The Oncology Institute, Inc.'s interest coverage.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is The Oncology Institute, Inc.'s interest coverage?
- The Oncology Institute, Inc. (TOI) reported interest coverage of -4.3× in Q1 2026.
- How has The Oncology Institute, Inc.'s interest coverage changed year-over-year?
- The Oncology Institute, Inc.'s interest coverage increased by 8.9% year-over-year, from -4.7× to -4.3×.
- What is the long-term trend for The Oncology Institute, Inc.'s interest coverage?
- Over 3 years (2020 to 2025), The Oncology Institute, Inc.'s interest coverage has grown at a -48.6% compound annual growth rate (CAGR), from -23.6× to -3.2×.
- What does interest coverage mean?
- Trailing-twelve-month operating income (EBIT) divided by interest expense. Measures how many times over the company can cover its interest payments from operating profit.